Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia
AssigneeIntermune, Inc.
InventorsRoderick Phillips, Lawrence M. Blatt
Life of this patent
Estimating the term…
Abstract
The invention disclosed herein relates to compositions and methods for treating subjects suffering from or at risk of developing neutropenia. In some embodiments, the methods comprise administering to a subject suffering from or at risk of developing neutropenia, an effective amount of pirfenidone and one or more toll-like receptor (TLR) agonists.
Claims28
A method of treating or inhibiting neutropenia in a subject in need thereof, the method comprising administering to said subject a therapeutically effective amount of pirfenidone and one or more toll-like receptor (TLR) agonists.
-7. (canceled)
-10. (canceled)
(canceled)
-21. (canceled)
-49. (canceled)
A composition comprising a therapeutically effective amount of pirfenidone co-formulated with one or more toll-like receptor (TLR) agonists.
(canceled)
(canceled)
-60. (canceled)
Dependencies are inferred from the claim text.